Merck blocked from selling injectable Keytruda in Europe after patent ruling
A Dutch patent court ruled in favor of Halozyme against Merck, ordering the drugmaker to halt manufacture and sale of injectable Keytruda in eight European countries due to patent infringement.
·2 sources
